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During  the  course  of our  work  on  the  interaction  of influenza  virus  with 
glycoproteins, it  became desirable  to isolate  highly potent  inhibitors  of viral 
hemagglutination in order to compare their properties and chemical composi- 
tion with other glycoproteins with  which the viruses react but which are not 
hemagglutination inhibitors.  One of the most active of such inhibitors can be 
demonstrated  in  erythrocytes.  It  appears  likely  that  this  inhibitor  may  be 
the  surface  component  with  which  the  viruses  combine  to  produce  hemag- 
glutination.  Several investigators  including de Burgh  (1),  McCrea  (2),  Green 
and Wooley (3),  Howe et al.  (4),  Klenk et al.  (5,  6),  and Kathan et al.  (7,  8) 
have  prepared  materials  from  erythrocytes  possessing  inhibitory  activity  to 
viral  hemagglutination.  The present  paper  describes  an  improved and  con- 
venient procedure which consistently yields a  product of very high inhibitory 
titer.  This  material  is  usually  homogeneous  according  to  the  criteria  which 
we  have  applied  including  paper  and  moving  boundary  electrophoresis  at 
several  pH  values  and  ultracentrifugal  analysis.  Chemical  studies  indicate 
that this material is a  glycoprotein. 
Materials and Methods 
Viru3.--Influenza virus, PR-8 and Lee strains, were propagated  by inoculating 10-day-old 
embryonated  chicken eggs with 0.1 ml. of a 1:1000 dilution of infective chorioallantoic fluid. 
The chorioal]antoic fluid was harvested after incubation for 48 hours at 35  ° C. Indicator virus 
was made by heating the fluid at 56  ° C. for 30 minutes. This was fitered for hemagglufinafion 
by the Salk method (9) and diluted with  0.9 per cent saline buffered at pH 7.4 with 0.15 m 
phosphate buffer (PBS) to 16 hemagglutination  uuits/ml,  and retitered  before use. One he- 
magglutination  (HA) unit is defined as that amount of virus which will just cause the hemag- 
glufination of 0.5 ml. of 0.S per cent human type 0, Rh-posifive red cells in a final volume of 
1 ml. 
Hemagglutination Inhibition Titration.--The hemagglutination  inhibitory  titer was deter- 
mined by making serial twofold dilutions of aqueous solutions of inhibitors in PBS. To 0.25 
ml. of the inhibitor  solutions was added  0.25 ml. of the indicator  virus  suspension (4 HA 
units), the mixture shaken, and kept at 4  ° C. for 10 minutes. One-half ml. of 0.5 per cent red 
* This work  was  carried  out under  support  from  United  States  Public  Health  Service 
grant E-2520. 
37 38  VIRAL  HEMAGGLUTINATION  INHIBITOR 
cell suspension was added to each tube. The tubes were shaken and then stored for at least 4 
hours at 4 ° C. before reading the pattern in the conventional manner. One hemagglutination 
inhibition (HAI) unit is defined as that amount of inhibitor which will just prevent the agglu- 
tination of 0.5 ml. of 0.5 per cent human red cells by 4 HA units of indicator virus. 
Analytical Procedures.--Sialic acid was determined by Bial's orcinol reaction and by the 
direct Ehrlich's reaction as given by Werner and Odin (10), and by the thiobarbituric acid 
method of Warren  (11). 
Hexosamine was determined by the method of  Morgan and  Elson  (12)  as modified  by 
Bogoch (13). 
Protein-bound hexose and fucose was determined by the methods described by Winzler 
(14) modified by omitting those steps necessary to precipitate the proteins. 
Nitrogen was determined by the method of Lang  (15)  involving nesslerization of diluted 
sulfuric acid digests. The digestion mixture was that recommended by  Campbell and Hanna 
(16). 
Phosphorus was determined by a modification of the method of Gericke and Kurmies (17). 
Chromatography of amino acids, hexoses, hexosamines, and sialic acid was performed using 
a  solvent system  of  ethyl acetate,  pyridine,  and  water in  volume proportions  of  10:4:3. 
Occasionally, for confirmation, a  solvent system of methyl ethyl ketone, acetone, water, and 
formic acid in the volume ratio of 30:10:10:1 was used as recommended by H6gstr6m (18). 
Descending chromatography on Whatman 3MM paper for 16 to 20 hours was employed. 
Staining of amino acids was accomplished with a spray of 0.4 per cent ninhydrin in acetone, 
or the buffered nirthydrin of Moore and Stein (19), followed by heating at  105  ° C. in an oven 
until color developed. Staining of hexoses and hexosamines was accomplished by spraying the 
separated constituents with aniline oxalate, as used by Partridge (20) or by ammoniacal silver 
nitrate  (21),  and heating in the oven until color developed.  Sialic acid  was  stained  with 
Ehrlich's reagent modified as follows: 4 gin. of paradimethylaminobenzaldehyde was dissolved 
in 40 ml. concentrated hydrochloric acid and 160 ml. methyl cellosolve. 
Electrophoresis was carried out on paper or in the Antweiler apparatus at several pH values 
ranging from 4.5  to 8.6 in 0.05 molar acetate, phosphate, or veronal buffers. High voltage 
paper electrophoresis was accomplished at 44 volts/cm, on Whatman No.  1 paper moistened 
with pyridine acetate buffer at pH 5.2 (100 volumes pyridine, 40 volumes glacial acetic acid, 
and 860 volumes water) suspended in heptane at  10  °  --  15  ° C.  Sedimentation studies were 
made in a  Spinco analytical ultracentrifuge with automatic temperature control at  59,780 
R.p.~r. Determinations were made in PBS at pH  7.4 and the sedimentation constants were 
corrected to 20  ° C. in water. 
RESULTS 
Preparation of the Inhibitor.- 
Six or more pints of type 0 Rh-positive blood were centrifuged, the plasma decanted, and 
the "buffy coat" of white cells skimmed off. The cells were washed three times with PBS by 
centrifugation to eliminate any residual plasma or white cells since both of these also contain 
inhibitor material.  The packed  cells were  then hemolyzed overnight with ten  times  their 
volume of distilled water at 4 ° C. The lysed cells were recovered by centrifugation at 700 G 
for  1 hour.  Residual hemoglobin was removed by washing the stroma with distilled water 
several times by centrifugation until no hemaglobin could be detected  in the supematant. 
The pH of the stromal suspension was adjusted to 5.5 and the suspension centrifuged at 690 
G for 30 minutes.  The packed  stroma  was  then frozen in this condition to serve as source 
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similar manner was  generously supplied  by Merck,  Sharpe and Dohme,  Inc.  1, West Point, 
Pennsylvania. 
As shown in Fig. 1, 30 gin. of the frozen material was thawed, 50 ml. of distilled water added, 
and the cold suspension homogenized in a  Waring blendor for 5 minutes. The finely divided 
suspension was adjusted to pH 8.0 with dilute NaOH and centrifuged for 2 hours at 700 G. It 
was found that the "fresh" (unfrozen) stroma source would not sediment easily at these cen- 
trifuge  speeds,  whereas the material once frozen for several days,  sedimented easily.  The 
insoluble residue was transferred to a  beaker containing 700 ml. of 50 per cent phenol (by 
volume) maintained at 68  ° -  70  ° C. and stirred for 10 minutes. The mixture was permitted 
to cool to room temperature and was centrifuged at 700 G for 60 minutes. The upper aqueous 
phase was decanted, dialyzed against running tap water until free of phenol, and lyophilized. 
Frozen Human Stroma 
J 
to 30 gin., add 50 ml. distilled H~O, homogenize, adjust to pH  8,  centrifuge 
700 G 
Insoluble Elinin 
l  add  700 ml. 50 per cent phenol, 68  °, stir  10 minutes cool to room  tempera- 
ture ,centrifuge at 700 G 
Phenol  Aqueous 
Layer  | Layer 
J. dialyze against tap H~O lyophilize 
Crude Inhibitor (yield about 200 rag.) 
~ 
to 30 mg., add  10 ml. CHCLa  -  MeOH,  2:1, shake 10 minutes add  10 ml. 
distilled H20, shake l0 minutes centrifuge at slow speed 
Chloroform  Aqueous 
Layer  | Layer 
$ centrifuge at 105,000 G decant solution, dialyze against distilled H20 lyophilize 
Pure Inhibitor (yield about 12 rag.) 
Fro. 1.  Method of preparation of inhibitor. 
The yield was about 200 mg. To 30 mg. aliquots of this material was added 10 ml. of a chloro- 
form-methanol solution (2 to 1 volume/volume) and the mixture  shaken for 10 minutes. An 
additional 10 ml. of distilled water was added, and the mixture again shaken for 10 minutes. 
Following centrifugation at  700  G,  the upper  aqueous  phase containing the inhibitor was 
decanted and recentrifuged at 105,000  G for 60 to 90 minutes. The supernatant solution was 
then dialyzed against cold distilled water and lyophilized. The yield was 12 to 14 rag. 
The material thus obtained has a  titer, of 8,000  to  16,000 HAI units/mg. 
against 4  HA units of influenza PR-8  indicator virus and 45,000  to  60,000 
HAI units/rag, against 4 HA units of the Lee strain of influenza virus in the 
indicator state.  The  titer decreases upon standing in  the  dry state-both at 
refrigerated temperatures and at  room temperature.  The inhibitory titer of 
the discarded residues rarely exceeded 64 to 128 HAI units/rag. 
Properties  of the Inhibitor.--The  inhibitor gave a  single narrow zone when 
subjected to paper  electrophoresis at pH values of 4.5,  6.2,  and  8.6,  and a 
1 We wish to thank Dr.  Benjamin Sanders for his cooperation in providing us with this 
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single peak in the Antweiler electrophoresis at  the same pH values. At pH 
4.5 and 6.2 the protein moved toward the negative electrode while at pH 8.6, 
it  moved to  the  positive  electrode.  Treatment  of  the  inhibitor  with  active 
influenza virus  resulted  in  a  single  band  with  a  decreased  electrophoretic 
mobility at pH 8.6. A single peak was obtained by ultracentrifugation over a 
period of 2 hours at 59,780  R.P.M. (Fig. 2).  Occasionally, a  higher molecular 
weight contaminant (S~20  ° >  17.0)  appeared to the extent of about 4 per cent. 
The sedimentation constant, extrapolated to zero concentration, and corrected 
to 20°C. and with water as solvent, was determined to be 2.165. The diffusion 
I  ] 
Fio. 2.  Ultracentrifugal pattern of inhibitor. Speed 59,780 R.r.~., 85 minutes, 40  ° bar 
angle, 15 mg./ml. 
constant, corrected similarly for temperature and solvent, was determined to 
RTs 
be  0.575  X  10  -6 cm3/sec.  By  employing  the  equation M  -  D (1-Vp)  and 
assum~ug  the product of  V  (partial  specific  volume)  and  p  (density)  to  be 
0.71-a  likely value within the range of most proteins-the  molecular  weight 
was calculated to be 31,400. 
Chromatography of the products  resulting from hydrolysis under various 
concentrations of acid (6 ~¢, 1.2 1% 0.12  N, 0.012  N, 0.0012  ~, distilled water) 
and for varying time periods (15, 60, and 150 minutes, and 20 hours) showed 
the presence of the following substances: lysine, arginine, asparfic acid, glu- 
tamic  acid,  glycine,  serine,  alanine,  proline,  valine,  histidine,  and  leucine, 
isoleucine, methionine, threonine, galactosamine, galactose, sialic acid, and pos- 11. H. KATHAN,  R. J. V~INZLER,  AND C. A. JOHNSON  41 
sibly glucosamine. Glucose, mannose, as well as other amino acids, were absent 
or were present in only trace amounts. The presence oI lysine, arginine, as- 
partic acid, and glutamic acid were confirmed by high voltage electrophoresis. 
Histidine was confirmed by high voltage electrophoresis and by the sulfanilic 
acid color test as described by Mann (22). 
Chemical analysis gave the data indicated in Table I. Application of the 
Liebermann-Burchard  reaction  showed  the  absence  of  cholesterol and  the 
Dische carbazole test (23) was negative for uronic acids. 
When aliquots of some of the hydrolysates mentioned above were titered 
for hemagglutination inhibitory activity, the results shown in Table II were 
obtained. It appeared that loss of inhibitory activity paralleled the appearance 
TABLE I 
Chemical Analysis 
Constituent  Dry weight 
Nitrogen 
Protein bound hexose (as galactose) 
Hexosamine (as glucosamine) 
Phosphorus 
Fucose 












of free sialic acid during mild acid hydrolysis. Most of the sialic acid occupies 
a terminal position, since it is almost completely removed from the protein by 
acid hydrolysis with 0.012  N hydrochloric acid at 100°C.  for  1 hour or 0.1  s 
sulfuric acid at 80°C. for 1 hour, without the release of any other substituent. 
The role of sialic acid in inhibitory activity was also established in another 
way. A sample of the inhibitor weighing 2.1 mg. was incubated with one-half 
ml. of 0.005 molar sodium periodate for 4 hours at pH 6 in the dark at room 
temperature. At the end of this period, 25 microliters of ethylene glycol was 
added to exhaust the remaining periodate. Aliquots were titered and shown 
to possess no inhibitory activity. To other aliquots of the periodate treated 
preparation were added equal volumes of 1.2 N HC1 or 0.12 •  HC1 and these 
werehydrolyzedat 100°C. for 1 and 3 hours. Under these conditions, sialic acid 
can be demonstrated in 0.06 N HCI hydrolysates and galactose and hexosamine 
in the 0.6 N  HC1  hydrolysates  of untreated inhibitor.  However,  the  perio- 
date-treated  samples did not liberate any sialic acid while the other carbohy- 
drates appeared in the usual amounts. The inhibitory activity of the protein 42  VIRAL  HENIAGGLUTINATION  INHIBITOR 
was totally destroyed when incubated with trypsin (1.2 mg./100 mg. protein; 
1 hour), with active influenza virus (256 HA units/rag, protein; 3  hours),  or 
with  crude  RDE from  Vibrio cholera (3 hours).  Lysozyme had no  effect on 
activity. Dr.  Georg  F.  Springer kindly tested our preparation for M  and  N 
blood group activity and found that it inhibits agglutinins anti-M and anti-N 
to a rather high degree. We have found no other blood group activity associated 
with this material. 
TABLE  II 
Hemagglutination I~.hibition Titers (PR-8 Indicator Virus) Following Hydrolysis 
under Stated Conditions 
Distilled H~O--37°C. 
Distilled H20--100°C. 
0.0012 ~  HCI--100°C. 
0.012 ~  HCI--100°C. 
0.12 N HCI--100°C. 








60 rain.  150 rain. 
4400 
O*  0 
O*  0 
0  0 
0  0 
Original titer was 8000 HAI units/mg. 
* Only  sialic  acid  identified  chromatographically  under  these  conditions  of  hydrolysis. 
DISCUSSION 
A procedure resulting in the isolation of a material from human erythrocytes 
possessing high inhibitory activity against influenza virus  hemagglufination 
has been described. It is felt likely that this material is the receptor substance 
with which the influenza virus reacts although this has not been conclusively 
established.  However,  some  evidence  can  be  submitted  in  support  of  this 
hypothesis. The material isolated is  the  only potent inhibitor found in  the 
various fractions obtained by our procedure,  and when the method is care- 
fully executed, the highest titer found in other fractions rarely exceeds  64 to 
128  HAI  units/rag.  Secondly, pretreatment  of  intact  red  cells  with  active 
influenza virus followed by preparation of the inhibitor in the usual manner 
results in a  material possessing no inhibitory titer against the same strain of 
virus. 
The preparation described in this paper differs in several ways from others 
previously isolated from erythrocytes in that (a) it has a much higher inhibitory 
titer, (b) it has a higher sialic acid content than others analyzed for this con- 
stituent, (c) it is more homogeneous than other preparations for which electro- 
phoretic  or ultracentrifugal data are  available.  Other minor differences also 
exist in terms of amino acid composition, and molar ratios of hexose to hexos- 
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sialic acid, hexose,  hexosamine, and fucose of approximately 10:10:10:1.  A 
minimum molecular weight based on fucose analysis would be in the vicinity 
of 14,500, a value  essentially one-half of the value of 31,400,  obtained from 
ultracentrifugal and diffusion studies. 
The fact that the inhibitor described here possesses M  and N  blood group 
activity deserves further emphasis since recently Stalder  and  Springer  (24) 
and Baranowski (25) have reported on purified blood group antigens M and N 
with properties very similar to materials which are described here. It has also 
been reported that M  and N  activity is destroyed by neuraminidase (26, 27). 
Should these materials be identical, it is possible that M  and N  blood group 
activity is associated with the site with which influenza viruses react. 
Although  many glycoproteins have  been  reported  to  contain  sialic  acid 
(28)  not all of these are hemagglutination inhibitors even though their sialic 
acid residues are removed by neuraminidase. Thus orosomucoid is not at all 
inhibitory to  viral  hemagglutination but  its  sialic acid  may be  completely 
removed by viral neuraminidase. There must, therefore, be structural differ- 
ences between inhibitors and non-inhibitors permitting both  to  act  as sub- 
strates but only certain types (29) to combine firmly with influenza virus. 
Studies  on  structural  similarities  and  differences  between  glycoproteins 
which  are  inhibitory  and  non-inhibitory  to  viral  hemagglutination  are  in 
progress employing the stromal inhibitor here described. 
SUMMARY 
A material, derived from human erythrocytes and believed to be identical 
with the receptor site for the myxoviruses, has been obtained in homogeneous 
form. The method of preparation involves pH adjustment of the stroma, hot 
phenolic extraction, cMoroform-methanol treatment, and ultracentrifugation. 
The  material  so  obtained possesses  a  high inhibitory titer  to  viral  hemag- 
glutination (45,000  to 60,000 inhibitory units/rag, against 4 hemagglutination 
units of Lee strain of influenza virus) and appears to be a  glycoprotein con- 
taining 22 to 24 per cent sialic acid, 12 per cent hexose, 12 per cent hexosamine, 
1 per cent fucose in addition to at least eleven amino acids. The sialic acid 
probably occupies a  terminal position in an  oligosaccharide chain extending 
from  the  protein  peptide  chain.  The  molecular  weight  is  near  30,000--an 
unusually low value for substances possessing this biological activity. M  and 
N blood group activity also seems to be associated with this protein. 
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